期刊文献+

重组人干扰素α-2b栓联合物理治疗宫颈上皮内瘤变Ⅰ级合并高危HPV阳性疗效观察 被引量:6

Therapeutic effect of recombinant human interferon α-2b suppository combined with physical therapy on Grade Ⅰ cervical intraepithelial neoplasia patients with high-risk HPV positive
下载PDF
导出
摘要 目的分析重组人干扰素α-2b栓联合物理治疗合并高危人乳头瘤病毒(HPV)阳性宫颈上皮内瘤变(CIN)Ⅰ级的疗效。方法选取某院CINⅠ级合并高危HPV阳性患者80例(2016年6月~2018年6月),依据随机数字表法分组,每组40例。对照组采用重组人干扰素α-2b栓治疗,研究组在对照组基础上采用物理治疗。比较两组CINⅠ级治疗有效率、治疗后3个月、6个月、9个月HPV转阴率、治疗前后HPV病毒载量、血清炎性因子[白细胞介素-6(IL-6)、白细胞介素-2(IL-2)]水平。结果研究组CINⅠ级治疗有效率89.74%高于对照组71.79%(P<0.05);治疗后3个月、6个月、9个月,研究组HPV转阴率66.67%、82.05%、92.31%高于对照组25.64%、43.59%、53.85%(P<0.05);与对照组比较,治疗后研究组HPV病毒载量较少,血清IL-6、IL-2水平较低(P<0.05)。结论重组人干扰素α-2b栓联合物理治疗CINⅠ级合并高危HPV阳性患者,可提高CINⅠ级治疗有效率,减少HPV病毒载量,减轻炎症反应,提高HPV转阴率。 Objective To analyze the efficacy of recombinant human interferonα-2b suppository combined with physical therapy for GradeⅠcervical intraepithelial neoplasia patients with high-risk HPV positive.Methods Eighty CIN I-grade patients with high-risk HPV positive(June 2016~June 2018)were enrolled in our hospital and grouped according to the random number table method,40 patients in each group.The control group was treated with recombinant human interferonα-2b suppository,and the study group was treated with physical therapy on the basis of the theraphy for the control group.The effective rate of CINⅠ,HPV negative rate at 3 months,6 months,and 9 months after treatment,the HPV viral load before and after treatment,serum inflammatory factors[interleukin-6(IL-6),interleukin-2(IL-2)]level were compared.Results The effective rate of CINⅠin the study group was 89.74%,higher than that in the control group 71.79%(P<0.05);At 3 months,6 months and 9 months after treatment,the HPV conversion rate of the study group was 66.67%,82.05%,92.31%higher than the control group 25.64%,43.59%,53.85%(P<0.05);In comparison,the HPV viral load was lower in the study group and the serumI L-6 and IL-2 levels of the study group were lower(P<0.05).Conclusion Recombinant human interferonα-2b suppository combined with physical therapy for GradeⅠcervical intraepithelial neoplasia patients with high-risk HPV positive can reduce HPV viral load,reduce inflammation and increase HPV conversion rate.
作者 林杏娟 肖文平 麦健敏 LIN Xing-juan;XIAO Wen-ping;MAI Jian-min(Department of gynaecology,zhongshan chenxinghai hospital,affiliated to guangdong medical university,Guangdong zhongshan 528415,China)
出处 《中国处方药》 2020年第2期108-109,共2页 Journal of China Prescription Drug
基金 中山市社会公益科技研究项目(2019B1030)
关键词 重组人干扰素Α-2B栓 物理治疗 高危HPV阳性 宫颈上皮内瘤变Ⅰ级 Recombinant human interferonα-2b suppository Physical therapy High-risk HPV positive Cervical intraepithelial neoplasia grade I
  • 相关文献

二级参考文献60

  • 1王华,陈亚宝,叶丽华,叶军,袁冬兰.应用支链DNA技术检测人乳头瘤病毒E6/E7mRNA在宫颈疾病筛查中的价值[J].中华临床医师杂志(电子版),2011,5(15):4362-4366. 被引量:29
  • 2李维国,王向东.新版《临床疾病诊断依据治愈好转标准》简介[J].解放军医院管理杂志,1998,5(3):299-299. 被引量:43
  • 3赵超,魏丽惠.干扰素α-2b对宫颈癌细胞HPV16 E6E7基因抑制作用的研究[J].中国妇产科临床杂志,2005,6(3):192-195. 被引量:14
  • 4Zhu D,Ye M,Zhang W,et al. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer eells[J-1. Int J Clin Exp Pathol,2015,8(5):4981-4989.
  • 5曹泽毅.中华妇产科学[M].6版.北京:人民卫生出版社,2005:2010-2012.
  • 6Wang HY, Park S, Lee D, et al. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cer- vical lesions[J]. Int J Infect Dis, 2015,8(37) : 135-142.
  • 7Paulraj F,Abas F,Lajis NH,et al. The curcumin analogue 1,5-Bis (2-hydroxyphenyl)-l, 4-pentadiene-3-one induces apoptosis and downregulates E6 and E7 oncogene expres- sion in HPV16 and HPV18-infected cervical cancer cells [J]. Molecules, 2015,20(7) : 11830-11836.
  • 8Cesur A, Nicol C, Groves H, et al. The subcellular local- isation of the human papillomavirus (HPV) 16 E7 protein in cervical cancer cells and its perturbation by RNA aptamers[J]. Viruses, 2015,7 (7) : 3443-3461.
  • 9Phaton R, Gutierrez J, Jiang Z, et al. Naive and radiola-beled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer[J]. Immunotherapy, 2015,7(6) : 631-640.
  • 10Li F, Cui J. Human telomerase reverse transeriptase regu-lates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer ceils [J]. Med ()ncol, 2015,32 ( 7 ) : 199- 200.

共引文献177

同被引文献53

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部